Dermatotherapy

  • Upload
    rushda

  • View
    217

  • Download
    0

Embed Size (px)

Citation preview

  • 7/23/2019 Dermatotherapy

    1/56

    TOPICAL DERMATOTHERAPYTOPICAL DERMATOTHERAPY

    Dr. dr. Farida Tabri, Sp.KK(K)

  • 7/23/2019 Dermatotherapy

    2/56

    The main requirement for

    topical dermatotherapy is

    selection of the suitable base,

    also called vehicle.

  • 7/23/2019 Dermatotherapy

    3/56

    Vehicle is used for those

    substance that bring

    specific drugs into contact

    with the skin.

  • 7/23/2019 Dermatotherapy

    4/56

    The most important vehicles

    for topical use divided into :

    I. Monophasic Vehicles.

    II. iphasic Vehicles.

    III. Triphasic Vehicles.

  • 7/23/2019 Dermatotherapy

    5/56

    !"#$%&

    !"#$%&

    "I' ( )*T

    "I' ( )*T 'I+I$

    'I+I$

    -ool

    !asta

    -ool

    !asta!*T*

    !*T* '"TI"/

    '"TI"/

    MPORTANT BASES FOR TOP CAL

    TREATMENT

    %M'TI"/ :

    -&%*M 0" ( #1"I/TM%/T 0# ( "1

    %M'TI"/ :

    -&%*M 0" ( #1"I/TM%/T 0# ( "1

  • 7/23/2019 Dermatotherapy

    6/56

    *. ' I + I $*. ' I + I $

    . Monophasic Vehicles

    2. aths :

    %ffect cleansing effect

    0crusts, scales, secretions1.

  • 7/23/2019 Dermatotherapy

    7/56

    %3ample : full bath, sit bath,

    foot bath, hand bath.

    ide effect : maceration

    0limited 45 minutes1.

    !reparation:

    ol acid salicyl.

    ol kalium permanganate.

  • 7/23/2019 Dermatotherapy

    8/56

    6. #et $ressing

    Type:

    "pen wet dressing

    rapid evaporation.

    -losed wet dressing

    retards evaporation.

  • 7/23/2019 Dermatotherapy

    9/56

    Indicated : superficial,

    inflammatory, crusted, 7erosive skin lesions.

    %ffect:

    -ooling.

    &educes swelling.

    *nti8inflammatory.

    oftening 7 removing

    accretion.

  • 7/23/2019 Dermatotherapy

    10/56

    ide %ffect:

    Maceration.

    Increase in bacterial

    growth.

  • 7/23/2019 Dermatotherapy

    11/56

    %ffect:

    -overing protective.

    -ooling.

    *nti8frictional.

    uperficial anti8inflammatory.

    $rying.

    . ! " # $ % &. ! " # $ % &

  • 7/23/2019 Dermatotherapy

    12/56

    Indicated:

    uperficial $ermatoses.

    %rythematous %3anthema.

    Vesicle or bullae

    protective.

    -ontraindicated : Madidans

    lesion.

  • 7/23/2019 Dermatotherapy

    13/56

    pecifics drugs contain:

    9inc o3ide.

    Magnesium o3ide.

    Titanium o3ide.

    ismuth subnitrate0preputial area1.

  • 7/23/2019 Dermatotherapy

    14/56

    ynonyms : shake lotion,

    liquid powder mi3ture.

    $efinition : suspensions of

    solid material in water or

    ethanol two phase systems.

    . Biphasic Vehicles

    *. ' " T I " /*. ' " T I " /

  • 7/23/2019 Dermatotherapy

    15/56

    %ffects:

    -ooling.

    *stringents.

    $rying.

    uperficial anti8inflammatory.

  • 7/23/2019 Dermatotherapy

    16/56

    Indicated:

    *cute, sub8acute 7

    superficial inflammatory

    dermatoses.

    eborrheic 7 intertrigenousdermatoses.

  • 7/23/2019 Dermatotherapy

    17/56

    ide effect:

    $rying action indicatedfor short term use.

    *brasive the powderparticle may clump.

    -ommercial preparations:

    -alamine !.

    -aladryl lotion.

  • 7/23/2019 Dermatotherapy

    18/56

    ynonym: hydrophilic cream.

    $efinition : emulsion of oil in

    water 0" ( #1, a two phase

    systems of water 7 fatty

    substances.

    . - & % * M. - & % * M

  • 7/23/2019 Dermatotherapy

    19/56

    %ffects :

    -ooling.

    *nti8inflammatory effect.

    Moisturiing 7 emollient

    effect.

    &apidly penetrate the skin.

    #ater washable.

  • 7/23/2019 Dermatotherapy

    20/56

    Indicated:

    $ermatitis acute ( sub8

    acute.

    -osmetic indication

    0cleansing or bodylotion1.

  • 7/23/2019 Dermatotherapy

    21/56

    -ontraindicated:

    $ry skin condition.Madidans lesion.

    ide effect:!romote drying 0prolong

    application1.

    !ruritic effect 0because

    evaporated tendency1

  • 7/23/2019 Dermatotherapy

    22/56

    ynonym: lipophilic cream.

    $efinition : emulsions of

    water in oil 0# ( "1, a two

    phase systems of fat and a

    limited amount of water

    0about 45;1.

    -. " I / T M % / T-. " I / T M % / T

  • 7/23/2019 Dermatotherapy

    23/56

    %ffect:

    -overing.

    oftening scales 7

    crusts.

  • 7/23/2019 Dermatotherapy

    24/56

    -ontraindicated:

    eborrheic condition.

    *cute inflammatory skin

    0Madidans lesion1. ide effect:

    !romote inflammation

    occlusion effect.

    !romote dyhidrosis.

  • 7/23/2019 Dermatotherapy

    25/56

    $efinition : ointment into

    which 65 8 =5; powder, atwo phase system or as

    highly concentratedsuspensions.

    $. ! * T *$. ! * T *

  • 7/23/2019 Dermatotherapy

    26/56

    %ffects:

    -ooling.

    *nti8inflammatory.

    ecretion > absorbing

    0drying1.

    kin protective action.

  • 7/23/2019 Dermatotherapy

    27/56

    Indicated :

    lcers.

    -hronic e3udative

    dermatoses.

    Thick lichenified plaque.

    econdary bacterial

    infection.

  • 7/23/2019 Dermatotherapy

    28/56

    -ontraindicated :

    *cute inflammatory

    skin.

    calp skin.

  • 7/23/2019 Dermatotherapy

    29/56

    $efinition : triphasic

    vehicles that consist of oil

    > water > powder mi3tures

    in varying proportions.

    . Triphasic Vehicles

    -""'I/< !*T*-""'I/< !*T*

  • 7/23/2019 Dermatotherapy

    30/56

    B.POWDER :

    %ffects:

    oothing.

    -ooling.

    #eeping skin.

    The basic formula for cooling

    pasta : inc o3ide, calcium

    hydro3ide solution, 7 oil.

  • 7/23/2019 Dermatotherapy

    31/56

    2. Tars.

    6. ?eratolytic drug.

    4. *ntibiotic drugs.

    @. *nti8fungal drugs.

    =. !arasiticides.

    A. -orticosteroids.

    Specific Topical Treatment

  • 7/23/2019 Dermatotherapy

    32/56

    $efinition : are produces

    by dry distillation of coal,

    wood, or peat.

    2. T * &2. T * &

  • 7/23/2019 Dermatotherapy

    33/56

    %ffects :

    *nti8pruritic.*nti8inflammatory.

    ?eratoplastic.

    *nti8infective actions.

    Indicated:

    -hronic lichenified.

    *topic ecema.

    !soriasis vulgaris.

  • 7/23/2019 Dermatotherapy

    34/56

    -ontraindicated : e3udative

    or infection dermatoses. ide effects:

    !hototo3ic dermatitis.Tar folliculitis.

    Tar acne.-arcinogenicity of coal

    tar 0long term use1.

  • 7/23/2019 Dermatotherapy

    35/56

    a. alicylic acid

    *t 'ow concentrations 05.= 8

    6;1, it has an antiseptic,

    keratoplastic, an anti8

    inflammatory action.

    6. ?%&*T"'BTI- $&

  • 7/23/2019 Dermatotherapy

    36/56

    *t a concentration of 4 8

    25;, it has keratolytics,loosen scales in psoriasis or

    hyperkeratotic ecema.

    ide effect : to3ic effect is

    used in large area

    0especially : children1.

  • 7/23/2019 Dermatotherapy

    37/56

    b.ulfur

    %ffect :

    *stringent action 06 8 25;1.

    *n anti8fungal 025;1.

    -osmetic 7 medical facial

    7 scalp preparation 0no

    sebum suppressive effect1.

  • 7/23/2019 Dermatotherapy

    38/56

    c. &esorcinol

    %ffect:

    $rying.

    *stringent.

    ?eratolytics effect 0highconcentration1.

    Indicated:

    caling dermatoses.-omedones acne 0by Vit *

    acid1.

  • 7/23/2019 Dermatotherapy

    39/56

    a. !enicillin can not

    recommend because oftheir high potential for

    contact sensitiation 7 not

    absorbed.

    4. */TII"TI- $&

  • 7/23/2019 Dermatotherapy

    40/56

    b.Tetracyclines :

    bacteriostatic

  • 7/23/2019 Dermatotherapy

    41/56

    d.

  • 7/23/2019 Dermatotherapy

    42/56

    f. !olymy3in : very broad

    pectrum, especially 0%.-oli, !seudomonas *1

    g./itrofuraone : bactericidal

    7 bacteriostatic

  • 7/23/2019 Dermatotherapy

    43/56

    h.-lindamycin : broad

    spectrum of !enicillin

    resistant 7 treatment for

    acne.

    %g : cleocin, sobelin.

  • 7/23/2019 Dermatotherapy

    44/56

    a. Tolnaftate : anti8fungal drug

    for all dermatophytes.

    %g : aftate, tinactin, tonoftal.

    @. */TI)/

  • 7/23/2019 Dermatotherapy

    45/56

    b.b. TolciclateTolciclate : analogue of: analogue of

    tolnaftate.tolnaftate.%g : fungifos.%g : fungifos.

    c.c. Imidaole derivatesImidaole derivates : for: fordermatophytoses,dermatophytoses, -andida-andida

    albicans, !ityriasis versicolor.albicans, !ityriasis versicolor.

    %g : canesten, mycospor,%g : canesten, mycospor,

    micatin.micatin.

  • 7/23/2019 Dermatotherapy

    46/56

    d.*mphotericin : anti8fungal

    antibiotic, especially for

    superficial infections.

    %g : fungione, ampho8

    moronal.

  • 7/23/2019 Dermatotherapy

    47/56

    e. /ystatin: no systemic action,

    minimally absorbed from

  • 7/23/2019 Dermatotherapy

    48/56

    a. enyl enoate : anti8

    scabies for infants 7

    children.

    =. !*&*ITI-I$%=. !*&*ITI-I$%

  • 7/23/2019 Dermatotherapy

    49/56

    b.De3achlorocyclohe3ane :

    antiscabies, antipediculosis,

    antiphtriasis.

    %g : lindane 0gamene, kwell,

    scabene1.

  • 7/23/2019 Dermatotherapy

    50/56

    c. -rotamiton : scabies,

    phtriasis, demode3folliculitis, 7 antipruritic

    drug.

    %g : eura3 lotion, crotamite3

    gel.

    c. Thiabendaole : creepingeruption, scabies 0E F5;

    cases are cleared1.

  • 7/23/2019 Dermatotherapy

    51/56

    %ffects:

    *nti8inflammatory.

    *nti8pruritic.

  • 7/23/2019 Dermatotherapy

    52/56

    a. Mild corticosteroid :

    hydrocortisone 5.2 > 6.=;.

    b.Moderate corticosteroid :

    clobetasone 5.5=;.

    @ group classification of

    topical corticosteroid :

  • 7/23/2019 Dermatotherapy

    53/56

    c. !otent corticosteroid :

    triamcinolone * 5.2;

    betamethasone 2G valerate

    5.=;.

    d.Digh potency corticosteroid:

    fluocinolone acetonide 5.6;.

  • 7/23/2019 Dermatotherapy

    54/56

    ide effects corticosteroid:

    *llergic contact dermatitis.

    *trophy 7 thinning of the

    epidermis.

    teroid acne.teroid striae.

  • 7/23/2019 Dermatotherapy

    55/56

    'eucoderma.

    teroid ulcer 0chronic

    venous insufficiency1.

    &ebound effect 0psoriasis

    vulgaris1.

  • 7/23/2019 Dermatotherapy

    56/56